Literature DB >> 12869083

What is the long-term outcome of the different subgroups of functional dyspepsia?

M Heikkinen1, M Färkkilä.   

Abstract

BACKGROUND: Functional dyspepsia is often a long-lasting disorder that accounts for substantial healthcare costs. It has been classified into subgroups assuming that it can guide management of dyspepsia. AIM: To evaluate the clinical significance of subgrouping functional dyspepsia in a long-term perspective study.
METHODS: Consecutive patients with dyspepsia identified by general practitioners were investigated. Those patients with functional dyspepsia (n=201) were enrolled in this study. Initially, patients were divided into five subgroups (ulcer-like, dysmotility-like, reflux-like, unspecified, and irritable bowel syndrome-like). Patients' medical histories were reviewed after 6-7 years, and the number and outcome of repeated investigations were analysed. At the end of follow-up, patients filled in a questionnaire similar to that at baseline, and were invited for gastroscopy.
RESULTS: Only 2% of patients developed peptic ulcer during follow-up, none of them were in the ulcer-like subgroup. When referrals to hospital and examinations during follow-up were registered, no statistically significant differences existed between subgroups. Patients with reflux-like dyspepsia made fewer revisits than others (P=0.02), but had used antidyspepsia drugs during the previous year more often (P=0.036). Stability of the subgroups over time was poor.
CONCLUSIONS: Functional dyspepsia is a long-lasting disorder with a very good prognosis. Subgroups of functional dyspepsia play only a minor role in prediction of the long-term outcome, and their usefulness in clinical practice is also hampered by subgroup instability over time.

Entities:  

Mesh:

Year:  2003        PMID: 12869083     DOI: 10.1046/j.1365-2036.2003.01685.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  9 in total

1.  Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.

Authors:  Andrew K Roorda; Samuel N Marcus; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-04-22       Impact factor: 3.199

2.  Natural course of functional dyspepsia after Helicobacter pylori eradication: a seven-year survey.

Authors:  Francesco di Mario; Nicoletta Stefani; Nadia Dal Bò; Massimo Rugge; Alberto Pilotto; Giulia Martina Cavestro; Lucas Giovanni Cavallaro; Angelo Franzé; Gioacchino Leandro
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

3.  Gastrointestinal hormone abnormalities and G and D cells in functional dyspepsia patients with gastric dysmotility.

Authors:  Mei-Rong He; Yu-Gang Song; Fa-Chao Zhi
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

4.  Association of genetic variants in GNβ3 with functional dyspepsia: a meta-analysis.

Authors:  Fei Dai; Yaping Liu; Haitao Shi; Shuqiong Ge; Jun Song; Lei Dong; Jingyun Yang
Journal:  Dig Dis Sci       Date:  2014-02-21       Impact factor: 3.199

5.  Gastrointestinal symptoms and associated factors in Chinese patients with functional dyspepsia.

Authors:  Jiao Yu; Shi Liu; Xiu-Cai Fang; Jun Zhang; Jun Gao; Ying-Lian Xiao; Li-Ming Zhu; Fen-Rong Chen; Zhao-Shen Li; Pin-Jin Hu; Mei-Yun Ke; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

6.  An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Kadur Ramamurthy Raveendra; Venkatappa Srinivasa; Kadur Raveendra Sushma; Joseph Joshua Allan; Krishnagouda Shankargouda Goudar; Hebbani Nagarajappa Shivaprasad; Kudiganti Venkateshwarlu; Periasamy Geetharani; Gopalakrishna Sushma; Amit Agarwal
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-16       Impact factor: 2.629

7.  Long-term Ultrasonographic Follow-up Study of Gastric Motility in Patients with Functional Dyspepsia.

Authors:  Daisuke Kamino; Noriaki Manabe; Jiro Hata; Ken Haruma; Shinji Tanaka; Kazuaki Chayama
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

8.  An economic model of long-term use of celecoxib in patients with osteoarthritis.

Authors:  Michael Loyd; Dale Rublee; Philip Jacobs
Journal:  BMC Gastroenterol       Date:  2007-07-04       Impact factor: 3.067

9.  Prevalence of dyspepsia and its correlation with demographic factors and lifestyle in shiraz, southern iran.

Authors:  F Khademolhosseini; D Mehrabani; N Zare; M Salehi; St Heydari; M Beheshti; M Saberi-Firoozi
Journal:  Middle East J Dig Dis       Date:  2010-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.